Lecture 20+21: Osteoarthritis Flashcards
Osteoarthritis pathophysiology
-degenerative changes that occur in cartilage and the associated bone
-inc destruction and proliferation
Osteoarthritis incidence
-older
-most-common joint disease
-worsens w age
-more common for women
Joints implicated in osteoarthritis
-distal interphalangeal joint
-hips
-knees
risk factors
-age
-weight
-defects
-muscle weakness
-woman
-stress
-trauma
-hereditary
Symptoms
-joint pain
-stiffness in morning
-crepitus
-inflammation
-muscle atrophy
-asymmetric involvement
Other manifestations
-no symptoms
-instabiliity of weight bearing joints
-herberden’s nodes
-bouchard’s nodes
Osteoarthritis first line treatment
-acetaminophen
-topical NSAIDs
-intramuscular corticosteroids
osteoarthritis second line treatment
-opiods
-surgery
-duloxetine
-intraarticular hyaluronates
Non-pharmacological treatment of osteoarthritis
-psychological support
-education
-rest
-exercise
-heat/ice
-physical therapy
-occupational therapy
-weight loss
Topical therapy
-menthol/camphor/wintergreen
-capsaicin cream
-diclofenac gel or topical solution
Menthol/Camphor/oil of wintergreen
-topical
-counterirritant
-aaa TID-QID
Capsaicin cream
-depletes substance P
-aaa TID-QID
-wait 2-4 weeks for full effect
Capsaicin cream adverse effects
-burning
-stinging
-redness
-symptoms go away with use
Diclofenac Gel (Voltaren Gel)
-COX-2 inhibition
-aaa 2-4g QID
-max 16g qd
-dont use in combo w systemic NSAID
Diclofenac gel adverse effects
-pruritus
-burning
-pain and rash
Diclofenac gel application
-measure
-apply
-massage
Diclofenac topical solution (pennsaid)
-for KNEE only
-40 drops each knee QID or
-apply 10 drops at a time or
-2 pumps BID
diclofenac solution adverse effects
-local reaction
Acetaminophen
-thought to inhibit prostaglandin synthesis in the CNS
-3-4g qd
-2-4 weeks
Acetaminophen cautions
-patients at risk for hepatotoxicity (liver disease and alcoholics)
-monitor ALT/AST annually if on routine dose
NSAIDs
-COX inhibitors
-analgesic dose lower than anti-inflammatory dose
-1-2 weeks for pain
-2-4 weeks for inflammation
NSAID therapy side effects
-GI
-ulcers
-bleeding
-renal dysfunction
-inc BP
-inc risk of stroke MI and death
NSAID at risk population
-dose dependent
-age
-GI bleed
-PUD
-anticoagulants
-antiplatelet
-glucocorticoids
patients at greatest risk for nephrotoxicity from NSAID
-CHF
-HTN
-ESRD
-dehydration
patients at greatest risk for cardiovascular adverse effects from NSAID
-CHF
-CVD
Monitoring NSAIDs
-BP
-signs of edema or weight gain
-SCr every 3 months
-Hgb / Hct 6-12 months
-signs of dehydration
COX-2 inhibitors
-celebrex
-100-200mg PO qd or BID
-lower incidence of GI bleeding
Risks w COX-2 inhibitors
-inc risk of CVD
-same effects on renal function
-inc cost of therapy
Combination products
-NSAID + PPI
-NSAID + misoprostol
-NSAID + H2 antagonist
NSAID + PPI
-naproxen + esomeprazole
NSAID + misoprostol
-diclofenac + Misoprostol
NSAID + H2 ANTAgonist
-ibuprofen + famotidine
SLIDE 44
SLIDE 44
Opioid Analgesics
-PRN for pain
-start low and go slow
-nausea, somnolence, constipation, dizziness
Tramadol
-affinity for u receptor
-25-50mg q4-6h
-titrate to 200-300mg/day
-nausea, vommiting, constipation, dizziness
Duloxetine
-adjunct medication
-30mg/day once a week
-max 60mg in one day
-avoid w tramadol
-GI effects
Glucosamine/Chonroitin
-OTC
-stimulates proteoglycan synthesis
-500 mg PO TID (G)
-400 mg PO TID (C)
-slow onset (4 weeks)- 3 month trial
Glucosamine adverse effects
-gas
-bloating
-cramping
-nausea
-inc bleeding risk
Intra-articular corticosteroid injections
-only used for isolated joints
-no more than every 3-6 months
-injection hurts
-repeat injection can cause damage
-peak relief in 7-10 days
Hyaluronate Injection
-temp inc viscosity
-inject into knee
-max relief 8-12 weeks
-for patients who do not tolerate treatments or are not candidates for surgery
-only minor swelling adverse effect
Joint replacement surgery
-relieves pain at rest
-restores function to joint
-lasts 10-15 years
Monitoring parameters
-pain
-joint stability and function
-risk of fall
-range of motion
-X-rays
-degree of disabiliity
-weight
-ADRs from medications
-complicance w non-drug measures
-QOL issues
Alternative treatments
-acupuncture
-target cartilage, synovial membrane, subchondral bone
-DMOAD (disease modifying osteoarthritis drugs)
-stem cell therapy